FDA approves new drug to treat pancreatic cancer
The U.S. Food and Drug Administration approved an ovarian cancer drug for the maintenance and treatment of pancreatic cancer, according to AstraZeneca and Merck.
Obamacare sign-ups steady as debate persists over the future of the program
More than 8 million people have signed up for coverage next year under former President Barack Obama's health care law, the government said Friday, a sign of continued demand for the program amid persistent uncertainty over its future.
These 5 deadly diseases have made an alarming comeback over the past decade
Some deadly diseases that seemed headed for eradication in recent decades have been making a scary comeback in the past 10 years.
New migraine drug shows promise in clinical trial to treat patients with no other options
Ubrogepant, a new class of drug to treat acute migraine attacks, shows promise to treat patients who have previously lacked other options.